Related Experiment Video

Updated: Nov 15, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

983

CYP3A gene variability and cancer cells response to the treatment

Martina Šemeláková1, Lenka Maliničová, Mária Macejová

  • 1Department of Medical Biology, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, Košice, Slovakia.

General Physiology and Biophysics
|March 3, 2021
PubMed

Insights

Cytochrome P450 (CYP450) enzyme variations, specifically CYP3A4 gene polymorphism, impact cancer cell drug response. This variability affects anti-cancer drug metabolism and treatment efficacy.

Area of Science:

  • Pharmacogenomics
  • Molecular Biology
  • Cancer Research

Background:

  • Cancer treatment efficacy is influenced by cytochrome P450 (CYP450) enzymes, particularly CYP3A4 and CYP3A5.
  • Understanding genetic variations in these enzymes is crucial for personalized cancer therapy.

Purpose of the Study:

  • To investigate the role of CYP3A4 gene polymorphism in protein activity.
  • To determine the influence of CYP3A4 variations on cancer cell response to anti-cancer drugs.

Main Methods:

  • Denaturing gradient gel electrophoresis (DGGE) to detect CYP3A4 cDNA variability.
  • Sequence analysis of CYP3A4 and CYP3A5 genes.
  • Assessment of gene expression, protein levels, and enzyme activity in 12 cancer cell lines.

Main Results:

  • Confirmed CYP3A4 gene polymorphism in parental HT-29 and oxaliplatin-resistant HT-29-OxR adenocarcinoma cell lines.
  • Observed variations in CYP3A4 gene expression, protein levels, and activity across different cancer cell lines.
  • Demonstrated differential responses to drug treatments between sensitive and resistant cell lines.

Conclusions:

  • CYP3A4 gene polymorphism significantly affects CYP3A4 protein activity and cancer cell drug response.
  • Variability in CYP3A enzymes can impact the overall efficacy of anti-cancer drugs and drug metabolism.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.9K
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.5K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.6K